Author Archives: Julian Upton

Baxter Receives Third FDA Warning for Misleading Promotional Material

By Julian Upton | Published: September 1, 2010
FDA issued a warning letter to Baxter International for making “misleading efficacy claims” about its lung drug Araplast NP, which is contraindicated in individuals with selective IgA deficiencies and prescribed to patients who are at increased risk of emphysema. FDA’s letter, dated Aug. 3, takes issue with claims in a brochure aimed at physicians that [...]
Posted in FDA | Tagged , , , , , | Leave a comment

And What Exactly is a Stakeholder?

By Julian Upton | Published: August 19, 2010
Pharma’s uncritical use of the word ‘stakeholder’ has increased to the point where it can refer to almost anyone connected to the industry. But this can have serious consequences, warns Reflector. Like it or not (and frankly, I don’t), stakeholders are here to stay in European pharmaceutical affairs. Don’t get me wrong. I’ve no objection to [...]
Posted in Europe, Global, Guest Blog, Regulatory | Tagged , , , , , , , , | 1 Comment

Patients Want to Talk. Do You?

By Julian Upton | Published: August 18, 2010
Why are companies rushing to the web when traditional engagement with patient groups remains so under-exploited, asks Jacky Law. It used to be so easy. Patients listened to doctors, doctors listened to pharma and everyone was happy. There was even a time when payers listened to pharma, reimbursing their prices with very few questions asked. Now [...]
Posted in E-Media, Europe, FDA, Global, Guest Blog, Legal | Tagged , , , , , | 1 Comment

Europe: Resisting the Anticompetitive Crusade

By Julian Upton | Published: July 23, 2010
It’s been another rocky few weeks for pharma in Europe. Particularly for big brand name companies. But necessity is proving the mother of invention, says Pharm Exec’s Brussels correspondent, Reflector. AstraZeneca suffered a serious setback at the start of July when the European General Court ruled that it had illegally prevented generic competition. The case dates [...]
Posted in Strategy | Tagged , , , , , , , | Leave a comment

The Bizarre European Political Bazaar

By Julian Upton | Published: July 9, 2010
Pharm Exec Europe’s Brussels correspondent Reflector is exasperated by some of the European Union’s more unusual institutional arrangements. A senior Spanish diplomat told Reflector recently that, on the face of it, the European Union is a crazy set-up. He was talking about some of its bizarre institutional arrangements — such as a Commission composed of 27 [...]
Posted in Strategy | Leave a comment